Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Cox

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Oncotarget|November 22, 2017
Transient targeting of the pancreatic cancer stroma as a 'fine-tuned' anti-tumor and anti-metastatic therapyClaire Vennin, Thomas R Cox, Marina Pajic, et al.
Nature Reviews. Cancer|July 20, 2012
The rationale for targeting the LOX family in cancerHolly E Barker, Thomas R Cox, Janine T Erler
Clinical & Experimental Metastasis|January 19, 2024
miRNAs in pancreatic cancer progression and metastasisEllie T Y Mok, Jessica L Chitty, Thomas R Cox
Calcified Tissue International|November 4, 2017
Established Models and New Paradigms for Hypoxia-Driven Cancer-Associated Bone DiseaseThomas R Cox, Janine T Erler, Robin M H Rumney
Biochemical Society Transactions|November 23, 2019
Targeting the lysyl oxidases in tumour desmoplasiaJessica L Chitty, Yordanos F I Setargew, Thomas R Cox
Cancers|May 25, 2019
LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer TumorigenicityCédric Zeltz, Elena Pasko, Thomas R Cox, et al.
Data in Brief|December 10, 2015
Dataset for the proteomic inventory and quantitative analysis of the breast cancer hypoxic secretome associated with osteotropismThomas R Cox, Erwin M Schoof, Alison Gartland, et al.
British Journal of Pharmacology|March 7, 2018
The extracellular matrix as a key regulator of intracellular signalling networksJordan F Hastings, Joanna N Skhinas, Dirk Fey, et al.
Gastroenterology|December 31, 2017
Reshaping the Tumor Stroma for Treatment of Pancreatic CancerClaire Vennin, Kendelle J Murphy, Jennifer P Morton, et al.
Cancers|October 23, 2021
Pirfenidone Reduces Epithelial-Mesenchymal Transition and Spheroid Formation in Breast Carcinoma through Targeting Cancer-Associated Fibroblasts (CAFs)Hamidreza Aboulkheyr Es, Thomas R Cox, Ehsan Sarafraz-Yazdi, et al.
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Oncotarget|November 22, 2017
Transient targeting of the pancreatic cancer stroma as a 'fine-tuned' anti-tumor and anti-metastatic therapyClaire Vennin, Thomas R Cox, Marina Pajic, et al.
Nature Reviews. Cancer|July 20, 2012
The rationale for targeting the LOX family in cancerHolly E Barker, Thomas R Cox, Janine T Erler
Clinical & Experimental Metastasis|January 19, 2024
miRNAs in pancreatic cancer progression and metastasisEllie T Y Mok, Jessica L Chitty, Thomas R Cox
Calcified Tissue International|November 4, 2017
Established Models and New Paradigms for Hypoxia-Driven Cancer-Associated Bone DiseaseThomas R Cox, Janine T Erler, Robin M H Rumney
Biochemical Society Transactions|November 23, 2019
Targeting the lysyl oxidases in tumour desmoplasiaJessica L Chitty, Yordanos F I Setargew, Thomas R Cox
Cancers|May 25, 2019
LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer TumorigenicityCédric Zeltz, Elena Pasko, Thomas R Cox, et al.
Data in Brief|December 10, 2015
Dataset for the proteomic inventory and quantitative analysis of the breast cancer hypoxic secretome associated with osteotropismThomas R Cox, Erwin M Schoof, Alison Gartland, et al.
British Journal of Pharmacology|March 7, 2018
The extracellular matrix as a key regulator of intracellular signalling networksJordan F Hastings, Joanna N Skhinas, Dirk Fey, et al.
Gastroenterology|December 31, 2017
Reshaping the Tumor Stroma for Treatment of Pancreatic CancerClaire Vennin, Kendelle J Murphy, Jennifer P Morton, et al.
Cancers|October 23, 2021
Pirfenidone Reduces Epithelial-Mesenchymal Transition and Spheroid Formation in Breast Carcinoma through Targeting Cancer-Associated Fibroblasts (CAFs)Hamidreza Aboulkheyr Es, Thomas R Cox, Ehsan Sarafraz-Yazdi, et al.
Pageof 10